Pituitary, Thyroid & Adrenal Disorders
From the Journals
Radioactive iodine shows no benefit in low-risk thyroid cancer
The study’s take-home message for clinicians should be to “stop systematic radioiodine ablation administration in low-risk thyroid cancer patients...
Latest News
Radiofrequency ablation an option for thyroid microcarcinoma
RFA might be a good option for high risk surgical patients and patients who forgo active surveillance.
Latest News
Radioactive iodine therapy linked to later malignancy
A SEER study confirms known risks, but also finds elevated rates of breast cancer.
Latest News
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinoma
Chemotherapy-induced toxic effects, such as renal dysfunction, have always been a major concern in nasopharyngeal carcinoma.
Commentary
Growth hormone therapy for certain children may help them reach their potential
When should parents consider growth hormone therapy? In what cases is it warranted for children? Dr. Jessica Sparks Lilley discusses the need for...
From the Journals
Biomarkers predict cardiovascular risk in chronic kidney disease patients
New models to stratify atherosclerotic cardiovascular disease risk may improve shared decision-making.
From the Journals
Seniors face higher risk of other medical conditions after COVID-19
The risk of a new condition being triggered by COVID is more than twice as high in seniors, compared with younger patients, new research suggests...
From the Journals
Men with hypersexual disorder may have oxytocin overload
Cognitive-behavioral therapy reduced both oxytocin levels and hypersexual behavior.
From the Journals
OTC melatonin supplement use rises fivefold over 20 years
The study was designed to evaluate the breadth of use of melatonin, rather than its effectiveness as a sleep aid.
Latest News
Preschool boys’ behaviors traced back to moms’ thyroid hormones
Changes in maternal thyroid hormone levels during pregnancy may predict whether male offspring are aggressive or withdrawn preschoolers.
From the Journals
Benign adrenal tumors linked to hypertension, type 2 diabetes
Benign adrenal tumors produce enough cortisol to cause hypertension or type 2 diabetes in more than 15% of patients in a prospective U.K. study....